Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can Low-Cost strategies tame high blood pressure in Low-Income nations?

NCT ID NCT07784647

Knowledge-focused Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Sep 01, 2026 · Updated 3 times

Summary

This study examines how primary healthcare facilities in Nigeria and Sri Lanka manage high blood pressure, assessing readiness and patient outcomes. Researchers will survey facilities and patients, measure blood pressure, and interview patients, caregivers, and healthcare providers. The goal is to understand current care practices and barriers to control, paving the way for future trials of affordable treatment strategies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could identify gaps in hypertension care and guide low-cost, scalable strategies to improve blood pressure control in low- and middle-income countries.
What could go wrong
This is an observational, formative study, so it will not test a treatment directly. Findings may not generalize beyond the specific regions studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,357 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Facility Survey (SARA): This survey will be conducted in family medicine clinics within primary care facilities where most patients with hypertension are managed. Patient Cross-Sectional Survey: Adults with hypertension attending primary healthcare facilities screened as part of Facility Survey (SARA) in Nigeria and Sri Lanka. Group Discussions and In-Depth Interviews: Participants will include adults with hypertension and their carers; healthcare providers (community health workers, nurses, and doctors or physicians); clinic administrators; and policymakers.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

SARA Facility Survey Inclusion Criteria: \- primary care facility must be located in the Federal Capital Territory in Nigeria, and in the Gampaha District in Sri Lanka Patient Cross-Sectional Survey Inclusion Criteria: * adult (age ≥18 years) * hypertensive (defined as prior documented diagnosis of hypertension, or current use of BP-lowering drugs for hypertension, or SBP ≥140 mmHg, and/or DBP ≥90 mmHg measured on two separate occasions) Patient Cross-Sectional Survey Exclusion Criteria: * receiving BP-lowering drugs for conditions other than hypertension (e.g., benign prostate hyperplasia, migraine, etc) * normotensive

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health services accessibility are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health services accessibility Hypertension

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • RemediumOne

    RECRUITING

    Colombo, Sri Lanka

  • University of Abuja

    RECRUITING

    Abuja, Federal Capital Territory, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.